Thanks Cabe6996. Unfortunately I don't have a view on future...

Thanks Cabe6996. Unfortunately I don't have a view on future valuation based on commercialization, waaaaay to many variables and hurdles to climb...

What I do know is that compared to its peers, and compared to where ANP market cap has been before with the progress of ATL1102, it is cheap. No problem at all seeing it towards 2 cents tomorrow.

Then if current trials are successful I see a move to 3 cents, and maybe 4 cents if it gets a tie in partner which it has done before.

To get above 4 cents I think there is years of trials and safety tests to complete.

In the background is this cancer trial. If it were to prove some efficay we could have a bizarre spike like Feb 2010, but can't predict or value that.

Nice buying today. Starting to look very sexy on the charts. Once again it was all one buyer, and there is really only one seller.

GL